Literature DB >> 24357809

In systemic sclerosis patients, bosentan is safe and effective for digital ulcer prevention and it seems to attenuate the development of pulmonary arterial hypertension.

Antonella Romaniello1, Giovanna Viola, Felice Salsano, Edoardo Rosato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24357809     DOI： 10.1093/rheumatology/ket424

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Is macitentan not a treatment option for digital ulcers in systemic sclerosis?

Authors:  Yoshihide Asano
Journal:  Ann Transl Med       Date:  2016-10

2.  D-optimal Design for Preparation and Optimization of Fast Dissolving Bosentan Nanosuspension.

Authors:  Elham Ghasemian; Parisa Motaghian; Alireza Vatanara
Journal:  Adv Pharm Bull       Date:  2016-06-30

3.  Effect of bosentan in pulmonary hypertension development in systemic sclerosis patients with digital ulcers.

Authors:  Ivan Castellví; Carmen Pilar Simeón; Monica Sarmiento; Jordi Casademont; Hèctor Corominas; Vicenç Fonollosa
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.